Health Agencies in Crisis: How the Federal Shutdown and Restructuring Disrupt US Healthcare

The biggest headline from the Department of Health and Human Services this week is the widespread impact of the federal government shutdown, which, as of October 1st, forced HHS to furlough more than 32,000 employees—over 40% of its workforce. Agencies like the CDC, NIH, and CMS have paused or slowed their activities, affecting everything from processing new drug applications and research grants to Medicare claims and telehealth regulations. CMS has instructed Medicare contractors to hold all claim payments until further notice, meaning hospitals and clinics won’t see reimbursement for new services, creating uncertainty for patients and providers. And for those who rely on telehealth, pre-pandemic restrictions are back for most services, with the exception of mental health care—so many patients may need to check with their providers about coverage. Leadership continues to signal a tough road ahead. Vice President JD Vance addressed the public, warning, “We are going to have to lay some people off if the shutdown continues.” Furthermore, infectious disease experts like Dr. Tina Tan and Dr. Anna Person are urging Congress to act swiftly, stressing that deep cuts to the health workforce and diverted CDC resources could endanger Americans, particularly those relying on routine disease surveillance, infectious disease care, or public health responses. Beyond the shutdown, HHS also quietly released a major overhaul of its Grants Policy Statement, effective October 1. The new policy sharply tightens requirements: for example, budget revisions of more than 10% now require prior approval, down from the previous 25%. There are changes to civil rights certifications, stricter rules for no-cost grant extensions, and language making clear that HHS can terminate awards for convenience with no appeal. Legal advisors are holding webinars to help grantees navigate these sweeping changes. In the midst of these disruptions, the department’s long-planned restructuring is moving forward. Five agencies are merging into the new Administration for a Healthy America, and the CDC will be refocused primarily on infectious diseases. HHS aims to save taxpayers $1.8 billion a year, but the changes will cut up to 20,000 jobs, with the deepest reductions at the CDC and FDA. Regional offices are consolidating, central support services are being streamlined, and certain CDC programs—like the National Center for Chronic Disease Prevention—are being eliminated or moved to states. For Americans, the immediate impact is a strain on public health oversight, delays in scientific research, and potential gaps in health coverage and program access. Businesses, especially Medicare providers and hospitals, face cash flow uncertainty and operational headaches. State governments may be asked to shoulder more responsibility for public health as federal agencies shrink. Internationally, the CDC’s reduced global health presence could weaken pandemic preparedness collaborations. Looking ahea This content was created in partnership and with the help of Artificial Intelligence AI.